SSH - GAINESVILLE INC — History
CCN 102022 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$24M
Latest Revenue (FY2022)
-3.9%
Revenue CAGR (3yr)
-0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $26M | $24M | -6.6% | -3.9% |
| Operating Expenses | $26M | $26M | $24M | -4.7% | -2.1% |
| Operating Margin | 3.2% | 1.7% | -0.3% | -119.2% | +0.0% |
| Net Income | $1M | $0M | $-0M | -117.9% | +0.0% |
| Licensed Beds | 48 | 48 | 48 | +0.0% | +0.0% |
| Total Patient Days | 15,622 | 15,376 | 14,463 | -5.9% | -3.8% |
| Medicare Day % | 43% | 36% | 39% | +8.0% | -5.0% |
| Medicaid Day % | 0% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.6% ($26M → $24M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.9%
This Hospital
+7.6%
State Avg
Latest Margin
-0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $23M | -2.1% |
| FY2024 (proj) | $22M | -3.9% |
| FY2025 (proj) | $21M | -5.7% |